Understanding & Managing Painful Sex During Menopause

Dyspareunia (painful intercourse) affects 17–45% of postmenopausal women. It's primarily driven by genitourinary syndrome of menopause (GSM)—entirely treatable. Suffering in silence is unnecessary.

Primary Causes

• Vaginal Atrophy (GSM): Estrogen loss → thinning, loss of elasticity, reduced lubrication, decreased vascularity. Tissue becomes fragile, easily traumatized.
• Vulvovaginal Dryness: Daily discomfort, not just with sex.
• Pelvic Floor Hypertonicity: Pain → guarding → muscle tightening → more pain (vicious cycle).
• Vestibulodynia: Localized pain at vaginal entrance. Hormonally mediated or neuroproliferative.
• Comorbidities: Diabetes, vascular disease, medications (SSRIs, antihistamines), autoimmune conditions, prior pelvic surgery/radiation.

Stepwise Treatment Approach

Tier 1: First-Line (Over-the-Counter / Non-Hormonal)

• Vaginal Moisturizers: Hyaluronic acid, polycarbophil, vitamin E based. Use 2–3x/week regularly (Replens, Hyalo GYN, Mae, Good Clean Love).
• Lubricants for Sex: Water-based (slippery, may need reapplication), silicone-based (long-lasting, condom-safe), oil-based (no latex condoms). pH ~4.5, osmolality <1200 mOsm/kg.
• Vulvar Care: Gentle cleansing (water only), cotton underwear, avoid irritants.

Tier 2: Local Hormonal Therapy (Gold Standard for GSM)

• Vaginal Estradiol: Cream (Estrace), tablet (Vagifem/Imvexxy), ring (Estring), insert (Intrarosa/DHEA).
• Low systemic absorption. Safe for most (including many breast cancer survivors — oncologist clearance).
• Improves thickness, elasticity, lubrication, pH, microbiome. 8–12 weeks for full effect.
• Maintenance: 2x/week indefinitely.

Tier 3: Advanced Medical

• Ospemifene (Osphena): Oral SERM for dyspareunia. Alternative if local estrogen contraindicated/declined.
• Pelvic Floor Physical Therapy: Manual therapy, dilators, biofeedback, down-training. Highly effective for hypertonicity.
• Topical Lidocaine 4–5%: Applied 10–15 min pre-intercourse for vestibulodynia.
• Laser/RF (MonaLisa Touch, ThermiVa): Stimulate collagen. Limited long-term data; not FDA-approved for GSM; costly; not covered by insurance.

Tier 4: Systemic Hormone Therapy

• If systemic symptoms (hot flashes, bone) also present. Discuss risk/benefit individually.

Critical Adjuncts

• Communication: "This hurts" → "Let's try X." Reduces anticipatory anxiety.
• Redefine Sex: Intercourse ≠ only penetration. Outercourse, mutual masturbation, toys, oral—pleasure without pain.
• Foreplay Extension: 20+ mins for arousal → natural lubrication, tenting.
• Position Modification: Woman-on-top controls depth/angle; side-lying reduces penetration depth.

When to Seek Care

• Pain persists >3 months despite moisturizers/lubricants.
• Bleeding, tearing, or new symptoms.
• Pain prevents desired intimacy.
• Provider dismisses concern ("normal for age").

Find a menopause-informed provider (NAMS-certified, ISSWSH member). GSM is a chronic condition requiring ongoing management—like hypertension, not a one-time fix. You can reclaim comfortable, pleasurable intimacy.